Published in J Biol Chem on September 18, 1998
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet (2005) 4.80
Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J (2000) 2.49
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J (2003) 1.75
Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol (2006) 1.64
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2. Nat Struct Mol Biol (2014) 1.64
Biology and significance of the JAK/STAT signalling pathways. Growth Factors (2012) 1.29
A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc Natl Acad Sci U S A (2000) 1.27
Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction. Mol Med (1998) 1.24
Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases. J Cell Mol Med (2010) 1.19
Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. EMBO J (1999) 1.15
Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited. Mol Cell Biol (2004) 1.01
Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes. Mol Cell Biol (2006) 0.95
Genetics of the type I interferon pathway in systemic lupus erythematosus. Int J Clin Rheumtol (2013) 0.90
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res (1999) 0.87
Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proc Natl Acad Sci U S A (2012) 0.87
Associations between PXK and TYK2 polymorphisms and systemic lupus erythematosus: a meta-analysis. Inflamm Res (2012) 0.86
Viral infections in type 1 diabetes mellitus - why the β cells? Nat Rev Endocrinol (2016) 0.83
West Nile virus infection induces depletion of IFNAR1 protein levels. Viral Immunol (2011) 0.83
Genetics of SLE: functional relevance for monocytes/macrophages in disease. Clin Dev Immunol (2012) 0.81
Jaks and stats as therapeutic targets. Ann Rheum Dis (2000) 0.79
Protein Alpha Shape Similarity Analysis (PASSA): a new method for mapping protein binding sites. Application in the design of a selective inhibitor of tyrosine kinase 2. J Comput Aided Mol Des (2002) 0.78
Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2). J Biol Chem (2015) 0.78
The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions. Front Endocrinol (Lausanne) (2017) 0.75
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin. Front Endocrinol (Lausanne) (2017) 0.75
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) (2017) 0.75
A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell (1992) 4.96
Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science (1994) 4.07
Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature (1982) 3.74
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
Genetic evidence equating SRY and the testis-determining factor. Nature (1990) 3.22
Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci U S A (1982) 3.11
A human Y-linked DNA polymorphism and its potential for estimating genetic and evolutionary distance. Science (1985) 2.88
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J (1989) 2.65
A view of the neolithic demic diffusion in Europe through two Y chromosome-specific markers. Am J Hum Genet (1996) 2.65
A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J (1995) 2.52
Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry (2002) 2.51
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Population structure in the Mediterranean basin: a Y chromosome perspective. Ann Hum Genet (2006) 2.28
The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon. EMBO J (1983) 2.28
The receptor of the type I interferon family. Curr Top Microbiol Immunol (2007) 1.94
GermOnline, a cross-species community knowledgebase on germ cell differentiation. Nucleic Acids Res (2004) 1.90
True hermaphroditism: genetic variants and clinical management. J Pediatr (1994) 1.84
Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet (2001) 1.84
Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem (1996) 1.78
Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull (2003) 1.76
Single-copy DNA sequences specific for the human Y chromosome. Nature (1983) 1.76
The protein encoded by a murine male germ cell-specific transcript is a putative ATP-dependent RNA helicase. Cell (1989) 1.75
Human XX males with Y single-copy DNA fragments. Nature (1984) 1.75
The type I interferon receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res (1999) 1.72
Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO J (1983) 1.71
Report of the committee on the genetic constitution of the X and Y chromosomes. Cytogenet Cell Genet (1987) 1.68
Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells. Eur J Immunol (1979) 1.65
A 11.7-kb deletion triggers intersexuality and polledness in goats. Nat Genet (2001) 1.62
Evolution and expression of FOXL2. J Med Genet (2002) 1.62
The common, Near-Eastern origin of Ashkenazi and Sephardi Jews supported by Y-chromosome similarity. Ann Hum Genet (1993) 1.59
Extensive sequence homologies between Y and other human chromosomes. J Mol Biol (1984) 1.58
Y chromosome DNA polymorphisms in human populations: differences between Caucasoids and Africans detected by 49a and 49f probes. Ann Hum Genet (1990) 1.53
Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons. Mol Cell Biol (1991) 1.52
A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science (1983) 1.51
A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci U S A (1993) 1.48
The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene (1999) 1.44
Persistence of Müllerian remnants in complete androgen insensitivity syndrome. J Pediatr Endocrinol Metab (2002) 1.42
Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J Biol Chem (1995) 1.41
Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. J Pathol (1996) 1.40
The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc Natl Acad Sci U S A (1997) 1.40
Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res (1997) 1.39
Association of the H-Y male antigen with beta2-microglobulin on human lymphoid and differentiated mouse teratocarcinoma cell lines. J Exp Med (1978) 1.38
The region on 9p associated with 46,XY sex reversal contains several transcripts expressed in the urogenital system and a novel doublesex-related domain. Genomics (2000) 1.32
Genetic evidence that ZFY is not the testis-determining factor. Nature (1990) 1.30
Bacterial signals and cell responses during Shigella entry into epithelial cells. Cell Microbiol (2000) 1.29
FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol (2008) 1.29
A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc Natl Acad Sci U S A (2000) 1.27
Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. J Exp Med (1979) 1.27
HLA class I genes integrated into murine cells are inducible by interferon. Eur J Immunol (1983) 1.27
Small deletions of the short arm of the Y chromosome in 46,XY females. Proc Natl Acad Sci U S A (1986) 1.27
Amplification and excision of integrated polyoma DNA sequences require a functional origin of replication. Cell (1984) 1.26
Regulation of polyomavirus late promoter activity by viral early proteins. J Virol (1986) 1.26
Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol (2001) 1.26
Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Natl Acad Sci U S A (1981) 1.25
p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study. Br J Cancer (1997) 1.21
Shared receptor components but distinct complexes for alpha and beta interferons. J Mol Biol (1998) 1.20
Characterization of a human ovarian teratocarcinoma-derived cell line. Int J Cancer (1980) 1.19
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet (2005) 1.18
Regional mapping of the HLA on the short arm of chromosome 6. Clin Genet (1979) 1.15
The Janus kinase family of protein tyrosine kinases and their role in signaling. Cell Mol Life Sci (1999) 1.15
Human interferon gamma receptor 1 (IFNGR1) gene maps to chromosome region 6q23-6q24. Hum Genet (1989) 1.14
Biological activities and receptor binding of two human recombinant interferons and their hybrids. J Gen Virol (1986) 1.14
Isolation of a human teratoma cell line which expresses F9 antigen. Nature (1977) 1.13
Interferon alpha inhibits a Src-mediated pathway necessary for Shigella-induced cytoskeletal rearrangements in epithelial cells. J Cell Biol (1998) 1.12
Gene sequence, localization, and evolutionary conservation of DAZLA, a candidate male sterility gene. Genomics (1997) 1.11
Absence of a serologically detectable association of murine beta2-microglobulin with the embryonic F9 antigen. Transplantation (1976) 1.11
Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res (2003) 1.11
Probable heploid expression of HL-A antigens on human spermatozoon. Nature (1970) 1.10
Deletions of distal 9p associated with 46,XY male to female sex reversal: definition of the breakpoints at 9p23.3-p24.1. Genomics (1997) 1.10
The p12f2/TaqI Y-specific polymorphism in three groups of Italians and in a sample of Senegalese. Gene Geogr (1987) 1.09
Diploid/triploid mosaicism: further delineation of the phenotype. Am J Med Genet (1994) 1.08
Negative regulation of type I interferon signaling: facts and mechanisms. Cell Mol Biol (Noisy-le-grand) (2006) 1.07
p53 mutations and histological type of invasive breast carcinoma. Cancer Res (1993) 1.06
Developmental expression of an early embryonic antigen common to mouse spermatozoa and cleavage embryos, and to human spermatozoa: its expression during spermatogenesis. Dev Biol (1976) 1.06
A new member of the cytokine receptor gene family maps on chromosome 21 at less than 35 kb from IFNAR. Genomics (1993) 1.06
Comparative genomic analysis of the interferon/interleukin-10 receptor gene cluster. Genome Res (1999) 1.06
p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene (1996) 1.05
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res (1993) 1.05
Endothelium and the brain in CNS lupus. Lupus (2003) 1.05
A five-generation family with sacral agenesis and spina bifida: possible similarities with the mouse T-locus. Am J Med Genet (1982) 1.05
Mutations and sequence variants in the testis-determining region of the Y chromosome in individuals with a 46,XY female phenotype. Hum Genet (1997) 1.04
Interferon enhances the amount of membrane-bound beta2-microglobulin and its release from human Burkitt cells. Eur J Immunol (1981) 1.04
Similar location of an early embryonic antigen on mouse and human spermatozoa. Dev Biol (1974) 1.03
IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett (1996) 1.03
Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics (1997) 1.03
The structure of the human interferon alpha/beta receptor gene. J Biol Chem (1992) 1.03
The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol (2007) 1.03
Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta. Eur J Biochem (1994) 1.03
The genetic basis of murine and human sex determination: a review. Heredity (Edinb) (1995) 1.03
Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int J Cancer (1997) 1.02